Guest Column | July 18, 2024

Extended GCP Training Is A “Must” For Cell And Gene Therapy Clinical Trials

By Jessica Cordes, senior consultant, Clinical Excellence GmbH

Cell and gene therapies (CGTs) carry specific challenges and risks in clinical trials for patients, investigators, and sponsors. So, all involved parties need proper training to ensure patient safety, data quality, and Good Clinical Practice (GCP) and regulatory compliance, especially regarding the guidelines for CGT therapies.

Please read the full Clinical Leader Article.